top of page

Meet Dr. GPCR Summit Partners

- Click to Explore -

Logo_domain_therapeutics_an_rev.png
logo-twistdivision.png
logo-gpcr-therapeutics.png
logo-montanamolecular.png
logo-synabs.png

Dr. GPCR Summit 2021

Live Talk Schedule

GPCRdb Resources

GPCRdb Resources

Dr. David Gloriam, Dr. Albert Kooistra, Gaspar Pandy-Szekeres

September 13, 2021 at 2:00:00 PM

CXCR4 heteromers as novel cancer targets

CXCR4 heteromers as novel cancer targets

Juan José Fung, Ph.D., Pina Cardarelli, Ph.D.,

September 13, 2021 at 5:00:00 PM

Unconventional GPCR Signaling in the Hedgehog Pathway

Unconventional GPCR Signaling in the Hedgehog Pathway

Dr. Ben Myers

September 13, 2021 at 6:00:00 PM

The Phosphorylation Barcode as a Mechanism of Biased β-arrestin 2 Recruitment and Conformation at CXCR3

The Phosphorylation Barcode as a Mechanism of Biased β-arrestin 2 Recruitment and Conformation at CXCR3

Dylan S. Eiger

September 13, 2021 at 7:00:00 PM

A distinct activation mechanism in GPCR dimers: Insights from cryo-EM snapshots of the entire Class D1 GPCR activation pathway

A distinct activation mechanism in GPCR dimers: Insights from cryo-EM snapshots of the entire Class D1 GPCR activation pathway

Vaithish Velazhahan

September 13, 2021 at 8:00:00 PM

Heat Shock Protein 90 is a Novel Opioid Receptor Signaling Regulator that can be Targeted to Improve Opioid Therapy

Heat Shock Protein 90 is a Novel Opioid Receptor Signaling Regulator that can be Targeted to Improve Opioid Therapy

Dr. John Streicher

September 13, 2021 at 9:00:00 PM

Through the Looking-Glass: Structure-Based Drug Discovery across the GPCRome

Through the Looking-Glass: Structure-Based Drug Discovery across the GPCRome

Dr. Chris de Graaf

September 14, 2021 at 12:00:00 PM

Designer G protein-coupled receptors as tools to identify novel targets for antidiabetic and anti-obesity drugs

Designer G protein-coupled receptors as tools to identify novel targets for antidiabetic and anti-obesity drugs

Jürgen Wess

September 14, 2021 at 1:00:00 PM

"Toolboxing" solid-state NMR spectroscopy for GPCR studies

"Toolboxing" solid-state NMR spectroscopy for GPCR studies

Dr. Jiafei Mao

September 14, 2021 at 2:00:00 PM

GPCRomics: Identifying novel GPCR targets in health and disease

GPCRomics: Identifying novel GPCR targets in health and disease

Paul A. Insel

September 14, 2021 at 3:00:00 PM

A Funny Thing Happened at the Dr. GPCR Summit

A Funny Thing Happened at the Dr. GPCR Summit

Dr. Robert Lefkowitz, Dr. Randy Hall

September 14, 2021 at 5:00:00 PM

Twist Biopharma: Synthetic DNA Technologies Enable Fast and Responsive anti-GPCR Antibody Discovery and Optimization

Twist Biopharma: Synthetic DNA Technologies Enable Fast and Responsive anti-GPCR Antibody Discovery and Optimization

Dr. Aaron K. Sato

September 14, 2021 at 7:00:00 PM

Advancing GPCR drug discovery with bioSensAll® platform technology

Advancing GPCR drug discovery with bioSensAll® platform technology

Dr. Meriem Semache

September 15, 2021 at 2:00:00 PM

GPCR activation mechanisms across classes and macro/micro scales

GPCR activation mechanisms across classes and macro/micro scales

Dr. David Gloriam

September 15, 2021 at 6:00:00 PM

Hydroxycarboxylic acid receptor 3 and GPR84 signaling with potential implications for immune cell function

Hydroxycarboxylic acid receptor 3 and GPR84 signaling with potential implications for immune cell function

Claudia Stäubert

September 15, 2021 at 7:00:00 PM

Engineering a human GPCR to create self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease

Engineering a human GPCR to create self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease

Benjamin M. Scott

September 15, 2021 at 8:00:00 PM

The challenges of targeting RXFP1, the receptor for the heart failure drug candidate relaxin, with peptide mimetics and small molecules

The challenges of targeting RXFP1, the receptor for the heart failure drug candidate relaxin, with peptide mimetics and small molecules

Ross AD Bathgate

September 15, 2021 at 9:00:00 PM

Profiling of GPCR complexes

Profiling of GPCR complexes

Kevin Pfleger

September 16, 2021 at 12:00:00 PM

Phosphorylation of the M1 muscarinic acetylcholine receptor protects from neurodegenerative disease

Phosphorylation of the M1 muscarinic acetylcholine receptor protects from neurodegenerative disease

Miriam Scarpa

September 16, 2021 at 1:00:00 PM

Innate Proximity: Utilizing the Inherent Physicality of Receptor Interactions for Drug Development

Innate Proximity: Utilizing the Inherent Physicality of Receptor Interactions for Drug Development

Dr. Ajay Yekkirala

September 16, 2021 at 2:00:00 PM

Chaperoning G protein-coupled receptors

Chaperoning G protein-coupled receptors

Ya-Xiong Tao

September 16, 2021 at 3:00:00 PM

Where a Ph.D. Can Lead

Where a Ph.D. Can Lead

Dr. Brian Arey, Dr. Samuel Hoare, Dr. Ajay Yekkirala, Dr. Stephanie Val

September 16, 2021 at 5:00:00 PM

FR900359: nature’s weapon and treasure trove for basic and translational research

FR900359: nature’s weapon and treasure trove for basic and translational research

Evi Kostenis

September 17, 2021 at 5:00:00 PM

Molecular basis of adhesion GPCR activation

Molecular basis of adhesion GPCR activation

Dr. Demet Araç

September 17, 2021 at 6:00:00 PM

Structure-guided drug discovery

Structure-guided drug discovery

Dr. Bryan Roth

September 17, 2021 at 7:00:00 PM

Nanobody tethering to dissect GPCR pharmacology

Nanobody tethering to dissect GPCR pharmacology

Dr. Ross Cheloha

September 17, 2021 at 8:00:00 PM

Structure and dynamics of GPCRs: lessons from cryo-EM

Structure and dynamics of GPCRs: lessons from cryo-EM

Dr. Patrick M. Sexton

September 17, 2021 at 9:00:00 PM

Meet Dr. GPCR Summit Partners

- Click to Explore -

Logo_domain_therapeutics_an_rev.png
logo-twistdivision.png
logo-gpcr-therapeutics.png
logo-montanamolecular.png
logo-synabs.png
bottom of page